Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Weatherald

Showing results (41-50 of 154) with videos related to

Pageof 16
Sort By:
The Lancet. Respiratory Medicine|August 23, 2021
Awake prone positioning in COVID-19: is tummy time ready for prime time?Jason Weatherald, John Norrie, Ken Kuljit S Parhar
Pulmonary Pharmacology & Therapeutics|April 9, 2017
Response to the article "Sorafenib as a potential strategy for refractory pulmonary arterial hypertension"Jason Weatherald, Marc Humbert, Christophe Guignabert, et al.
The European Respiratory Journal|March 31, 2018
Risk assessment in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Marc Humbert, et al.
The Canadian Journal of Cardiology|July 12, 2019
Pulmonary Embolism: The Value of the Angiographic DiagnosisBenjamin Leis, Jason Weatherald, Rashpal Basran, et al.
Canadian Respiratory Journal|February 10, 2015
Bronchoscopic resection of a central typical carcinoid tumourJason Weatherald, Naushad Hirani, Eve-Lea Beaudoin, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 8, 2017
Exertional dyspnoea in pulmonary arterial hypertensionDaniel Dumitrescu, Olivier Sitbon, Jason Weatherald, et al.
Chest|December 9, 2023
Ambitions for Pulmonary Arterial Hypertension Composite End Points: A Chain Is Only as Strong as Its Weakest LinkJason G E Zelt, Jason Weatherald, Stephen C Mathai
European Respiratory Review : an Official Journal of the European Respiratory Society|June 16, 2017
Mechanisms, measurement and management of exertional dyspnoea in asthma: Number 5 in the Series "Exertional dyspnoea" Edited by Pierantonio Laveneziana and Piergiuseppe AgostoniJason Weatherald, M Diane Lougheed, Camille Taillé, et al.
Seminars in Respiratory and Critical Care Medicine|June 27, 2023
Management of Pulmonary Arterial HypertensionJason Weatherald, Rhea A Varughese, Jonathan Liu, et al.
American Journal of Respiratory and Critical Care Medicine|December 20, 2017
The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?Jason Weatherald, Athénaïs Boucly, Sandeep Sahay, et al.
Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
The Lancet. Respiratory Medicine|August 23, 2021
Awake prone positioning in COVID-19: is tummy time ready for prime time?Jason Weatherald, John Norrie, Ken Kuljit S Parhar
Pulmonary Pharmacology & Therapeutics|April 9, 2017
Response to the article "Sorafenib as a potential strategy for refractory pulmonary arterial hypertension"Jason Weatherald, Marc Humbert, Christophe Guignabert, et al.
The European Respiratory Journal|March 31, 2018
Risk assessment in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Marc Humbert, et al.
The Canadian Journal of Cardiology|July 12, 2019
Pulmonary Embolism: The Value of the Angiographic DiagnosisBenjamin Leis, Jason Weatherald, Rashpal Basran, et al.
Canadian Respiratory Journal|February 10, 2015
Bronchoscopic resection of a central typical carcinoid tumourJason Weatherald, Naushad Hirani, Eve-Lea Beaudoin, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 8, 2017
Exertional dyspnoea in pulmonary arterial hypertensionDaniel Dumitrescu, Olivier Sitbon, Jason Weatherald, et al.
Chest|December 9, 2023
Ambitions for Pulmonary Arterial Hypertension Composite End Points: A Chain Is Only as Strong as Its Weakest LinkJason G E Zelt, Jason Weatherald, Stephen C Mathai
European Respiratory Review : an Official Journal of the European Respiratory Society|June 16, 2017
Mechanisms, measurement and management of exertional dyspnoea in asthma: Number 5 in the Series "Exertional dyspnoea" Edited by Pierantonio Laveneziana and Piergiuseppe AgostoniJason Weatherald, M Diane Lougheed, Camille Taillé, et al.
Seminars in Respiratory and Critical Care Medicine|June 27, 2023
Management of Pulmonary Arterial HypertensionJason Weatherald, Rhea A Varughese, Jonathan Liu, et al.
American Journal of Respiratory and Critical Care Medicine|December 20, 2017
The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?Jason Weatherald, Athénaïs Boucly, Sandeep Sahay, et al.
Pageof 16